Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life ⊕
Life sciences stocks are seeing a resurgence — and that's good news for Danaher.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Danaher
since
auto-detected in 6 stories
3 days ago
31 days ago
Danaher stock may be turning the corner. What needs to happen to keep it that way ⊕
Danaher's rebound is generating optimism, but there's still work ahead for the company to hit is 2026 growth targets.
46 days ago
Danaher gives investors reasons to stick around, sending beaten-up shares flying ⊕
The supplier of tools to drugmakers and hospitals is set up for a stronger 2026.
4 months ago
Danaher's imperfect quarter is good enough for us to stay the course
Shares fluctuated between gains and losses in Tuesday's session.
5 months ago
Our bottom 5 stocks for the first half of 2025 — and why we still own them
This is what it will take to for a turnaround in shares of Salesforce, Apple, Bristol Myers, DuPont and Danaher.
7 months ago
Danaher's quarterly results show signs of life, and the struggling stock soars
Count us among the Danaher investors breathing a sigh of relief.
page 1 of 1